Extendicare (EXETF) Expected to Post Earnings on Thursday

Extendicare (OTCMKTS:EXETFGet Free Report) will likely be issuing its results after the market closes on Thursday, August 6th. Analysts expect the company to announce earnings of $0.2781 per share and revenue of $399.3230 million for the quarter.

Extendicare Trading Down 2.0%

Shares of Extendicare stock traded down $0.51 during trading hours on Tuesday, hitting $24.80. 1,015 shares of the company’s stock traded hands, compared to its average volume of 49,661. Extendicare has a 12-month low of $8.95 and a 12-month high of $28.45. The company has a fifty day simple moving average of $24.99 and a 200-day simple moving average of $21.59.

Analyst Ratings Changes

EXETF has been the subject of a number of research analyst reports. TD Securities restated a “buy” rating on shares of Extendicare in a report on Monday, May 11th. Canadian Imperial Bank of Commerce reissued an “outperform” rating on shares of Extendicare in a research report on Monday, May 11th. Five analysts have rated the stock with a Buy rating, According to MarketBeat, Extendicare has a consensus rating of “Buy”.

View Our Latest Stock Report on Extendicare

About Extendicare

(Get Free Report)

Extendicare Inc (OTCMKTS:EXETF) is a Canada-based senior care provider headquartered in Markham, Ontario. The company specializes in the ownership and operation of long-term care homes, retirement residences and home health care services. It is publicly listed on the Toronto Stock Exchange under the symbol EXE and trades in the over-the-counter market as EXETF.

Extendicare’s operations are organized into two primary segments. The Long-Term Care & Retirement Living division operates approximately 120 facilities under the Extendicare and EspritVitalitĂ© banners, serving residents in Ontario, Alberta, Saskatchewan and parts of Atlantic Canada.

Further Reading

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.